Polymer-attached zanamivir inhibits synergistically both early and late stages of influenza virus infection
Covalently conjugating multiple copies of the drug zanamivir (ZA; the active ingredient in Relenza) via a flexible linker to poly-l-glutamine (PGN) enhances the anti-influenza virus activity by orders of magnitude. In this study, we investigated the mechanisms of this phenomenon. Like ZA itself, the...
Egile Nagusiak: | Lee, Chia Min, Weight, Alisha Kessel, Haldar, Jayanta, Wang, Ling, Klibanov, Alexander M., Chen, Jianzhu |
---|---|
Beste egile batzuk: | Massachusetts Institute of Technology. Computational and Systems Biology Program |
Formatua: | Artikulua |
Hizkuntza: | en_US |
Argitaratua: |
National Academy of Sciences (U.S.)
2013
|
Sarrera elektronikoa: | http://hdl.handle.net/1721.1/81198 https://orcid.org/0000-0003-3830-714X https://orcid.org/0000-0002-5687-6154 |
Antzeko izenburuak
-
Attaching zanamivir to a polymer markedly enhances its activity against drug-resistant strains of influenza a virus
nork: Weight, Alisha Kessel, et al.
Argitaratua: (2012) -
Zanamivir Conjugated to Poly-L-Glutamine is Much More Active Against Influenza Viruses in Mice and Ferrets Than the Drug Itself
nork: Belser, Jessica A., et al.
Argitaratua: (2014) -
Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
nork: Burls, A, et al.
Argitaratua: (2002) -
Zanamivir for the treatment of influenza in adults: a systematic review and economic evaluation.
nork: Burls, A, et al.
Argitaratua: (2002) -
Non-Aqueous Suspensions of Antibodies are Much Less Viscous Than Equally Concentrated Aqueous Solutions
nork: Srinivasan, Charudharshini, et al.
Argitaratua: (2016)